Article
VEGF gene polymorphism and response to intravitreal bevacizumab and triple therapy in age-related macular degeneration.
Japanese journal of ophthalmology - 1 Sept 2011
Nakata Isao, Yamashiro Kenji, Nakanishi Hideo, Tsujikawa Akitaka, Otani Atsushi, Yoshimura Nagahisa
Abstract excerpt
PURPOSE: To investigate the association between the vascular endothelial growth factor (VEGF) gene and response to either intravitreal bevacizumab (IVB) or photodynamic therapy with intravitreal triamcinolone acetonide and IVB (triple therapy) for neovascular age-related macular degeneration (AMD). METHODS: The study consisted of 94 patients with neovascular AMD who underwent IVB and 79 patients with neovascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
